- Home
- TLSA vs DOMO Comparison
TLSA vs DOMO Comparison
Compare TLSA & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSA | DOMO |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.6M | 189.3M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TLSA | DOMO |
|---|---|---|
| Price | $1.29 | $3.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $11.15 |
| AVG Volume (30 Days) | 170.5K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $317,044,000.00 |
| Revenue This Year | N/A | $3.41 |
| Revenue Next Year | N/A | $4.72 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.87 | $2.39 |
| 52 Week High | $2.60 | $18.49 |
Technical Indicators
Market Signals| Indicator | TLSA | DOMO |
|---|---|---|
| Relative Strength Index (RSI) | 50.73 | 46.45 |
| Support Level | $1.24 | N/A |
| Resistance Level | $1.60 | $5.39 |
| Average True Range (ATR) | 0.10 | 0.24 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 62.50 | 71.35 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.